脑淀粉样血管病与认知障碍及抑郁症状的关联
本研究在记忆与卒中预防门诊招募 probable CAA 患者和对照,横断面分析显示 CAA 与各认知域较差表现相关,CAA 组「可能抑郁」的比值比为 15.71(95%CI 4.26-80.05,p<0.001),GDS-15 评分为对照的 2.71 倍。抑郁症状部分介导 CAA 对情景记忆和执行功能的影响,CAA 神经影像标志与 GDS-15 评分相关。
要点
- CAA 患者「可能抑郁」风险显著高于对照,GDS-15 评分约为对照的 2.71 倍。
- 抑郁症状部分介导 CAA 对情景记忆和执行功能的影响,但不介导处理速度。
- CAA 患者中,皮层厚度降低、皮层表面铁沉积和 CAA 小血管病总评分与 GDS-15 评分相关。
核心结论
- CAA 患者比对照表现出更重的抑郁症状和更差的认知表现。
- 抑郁症状介导了 CAA 与认知关联的一小部分。
- 皮层损伤可能是一些抑郁症状的基础。
研究设计与样本
- 横断面研究,通过 2 个站点的记忆和卒中预防门诊招募 probable CAA 患者和对照。
- 共纳入 85 例 CAA(平均年龄 73.5 岁;女性 35.3%)和 83 例对照(平均年龄 68.8 岁;女性 62.7%)。
- 神经心理测试归为情景记忆、执行功能和加工速度三个认知域。
- GDS-15 评分≥5 定义为「可能抑郁」。
- 采用回归和中介分析检验 CAA 状态、认知与抑郁症状的关联,并在 CAA 患者中分析神经影像标志与 GDS-15 的关联。
主要发现
- CAA 状态与各认知域较差表现相关。
- 较高的 GDS-15 评分与各认知域较差表现相关。
- CAA 参与者「可能抑郁」的比值比为 15.71(95%CI 4.26-80.05,p<0.001)。
- CAA 参与者 GDS-15 评分为对照的 2.71 倍(95%CI 2.10-3.51,p<0.001)。
- 「可能抑郁」介导 CAA 对情景记忆(11%;β=-0.14,95%CI -0.30 至 -0.03,p=0.014)和执行功能(9%;β=-0.14,95%CI -0.30 至 -0.02,p=0.016)的影响,但不介导处理速度(2%;β=-0.04,95%CI -0.18 至 0.08,p=0.56)。
关键数值与推荐
- GDS-15 评分≥5 定义为「可能抑郁」。
- CAA 参与者「可能抑郁」比值比 15.71(95%CI 4.26-80.05,p<0.001)。
- CAA 参与者 GDS-15 评分为对照的 2.71 倍(95%CI 2.10-3.51,p<0.001)。
- 「可能抑郁」介导 CAA 对情景记忆效应的 11%(β=-0.14,95%CI -0.30 至 -0.03,p=0.014)。
- 「可能抑郁」介导 CAA 对执行功能效应的 9%(β=-0.14,95%CI -0.30 至 -0.02,p=0.016)。
临床怎么用
- 在 CAA 患者中应评估抑郁症状,因其与更差的认知表现相关。
- 针对 CAA 相关神经变性和抑郁症状的干预可能有助于支持 CAA 患者的认知健康。
- CAA 患者的皮层厚度降低、皮层表面铁沉积和小血管病总评分较高时,需关注抑郁症状。
局限性
- 横断面设计无法推断因果关系。
- 样本量有限(85 例 CAA 和 83 例对照)。
- 招募自记忆和卒中预防门诊,可能存在选择偏倚。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Cerebral amyloid angiopathy (CAA) is associated with intracerebral hemorrhage, cognitive decline, and dementia. We examined (1) associations between CAA, cognitive impairment, and depressive symptoms; (2) whether depressive symptoms mediate the relationship between CAA and cognition; and (3) whether CAA neuroimaging markers predict depressive symptom severity. METHODS: Recruitment occurred through memory and stroke prevention clinics across 2 sites. Cross-sectional data from probable CAA and controls were analyzed. Neuropsychological tests were grouped into episodic memory, executive function, and processing speed domains. Scores ≥5 on the Geriatric Depression Scale: Short Form (GDS-15) defined "possible depression." Regression and mediation analyses examined associations among CAA status, cognition, and depressive symptoms, and in CAA, associations between neuroimaging biomarkers and GDS-15. RESULTS: In 85 CAA (mean age 73.5; 35.3% female) and 83 controls (mean age 68.8; 62.7% female), CAA status was associated with poorer performance across cognitive domains. Higher GDS-15 scores were associated with poorer performance across domains. CAA participants had higher odds of "possible depression" (odds ratio 15.71; 95% CI 4.26-80.05, p < 0.001) and scored 2.71 times higher on the GDS-15 than controls (95% CI 2.10-3.51, p < 0.001). In mediation, "possible depression" accounted for significant proportions of the effect of CAA on episodic memory (11%; β = -0.14, 95% CI -0.30 to -0.03, p = 0.014) and executive function (9%; β = -0.14, 95% CI -0.30 to -0.02, p = 0.016), but not processing speed (2%; β = -0.04, 95% CI -0.18 to 0.08, p = 0.56). In 81 CAA participants, higher GDS-15 scores were associated with lower mean cortical thickness (count ratio [CR] 1.33 per SD decrease in thickness, 95% CI 1.09-1.62, p = 0.005), presence of cortical superficial siderosis (CR 2.04, 95% CI 1.35-3.09, p < 0.001), and higher CAA small vessel disease total score (CR 1.16, 95% CI 1.00-1.35, p = 0.047). DISCUSSION: CAA participants exhibited greater depressive symptoms and poorer cognition than controls. Depressive symptoms mediated a small portion of the association between CAA and cognition. Cerebral cortex damage may underlie some depressive symptoms. Interventions targeting CAA-related neurodegeneration and treatment of depressive symptoms may support cognitive health in CAA.
引用
- Nukala N, Muir RT, Beaudin AE, et al. Associations Between Cerebral Amyloid Angiopathy, Cognitive Impairment, and Depressive Symptoms. Neurology. 2026. PMID: 42555885. doi:10.1212/WNL.0000000000218354
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。